Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 12/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 12/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 12/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | CLK4 | Q9HAZ1 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 5/20 | 0.39 |
| ▸ | USP2 | O75604 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 8/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27090398 | 1.00 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL29610848 | 0.81 | HRAS (0.47) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL27090412 | 0.81 | HRAS (0.47) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL24313850 | 0.80 | PRMT5 (0.47) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL29611468 | 0.80 | PRMT5 (0.47) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL29610954 | 0.80 | PRMT5 (0.47) | CYP1A2CYP3A4CYP2C19CYP2D6MAPK1 | |
| SCHEMBL17106768 | 0.79 | UPP1 (0.44) | CYP1A2CYP2C19CYP2D6ALDH1A1LMNA | |
| SCHEMBL17106770 | 0.79 | UPP1 (0.44) | CYP1A2CYP2C19CYP2D6ALDH1A1LMNA | |
| SCHEMBL17106836 | 0.79 | METTL3 (0.49) | PRMT5METTL3 | |
| SCHEMBL17106699 | 0.79 | UPP1 (0.44) | CYP1A2CYP2C19CYP2D6ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240051985-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS INC (US) | 2024-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240051985-A1 | METTL3 MODULATORS | METTL3, METTL16, METTL14 | CYP1A2 1036/4885CYP3A4 426/4885CYP2C19 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.